Literature DB >> 18388937

The prion organotypic slice culture assay--POSCA.

Jeppe Falsig1, Adriano Aguzzi.   

Abstract

Methods enabling prion replication ex vivo are important for advancing prion science. However, few such technologies exist and many prion strains are intractable with them. Here, we describe a prion organotypic slice culture assay (POSCA), which allows for prion amplification and titration ex vivo under conditions that closely resemble intracerebral infection. Organotypic slices are incubated with infectious inoculum as free-floating sections, washed and cultured for up to 8 weeks. Slice cultures are a rich source of protein or RNA and allow for stringent comparisons between uninfected and prion-infected samples generated from the same mouse. Thirty-five days after contact with prions, cerebellar slices have amplified PrP(Sc) quantitatively similar to that seen in vivo, but accelerated fivefold. The POSCA detects replication of specific prion strains from disparate sources, including bovines and ovines, with variable efficiency. The culture procedure and prion infection can be performed in 8 h.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388937     DOI: 10.1038/nprot.2008.13

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  41 in total

Review 1.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Ruminant organotypic brain-slice cultures as a model for the investigation of CNS listeriosis.

Authors:  Claudia Guldimann; Beatrice Lejeune; Sandra Hofer; Stephen L Leib; Joachim Frey; Andreas Zurbriggen; Torsten Seuberlich; Anna Oevermann
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

Review 3.  Prion neurotoxicity.

Authors:  Nhat T T Le; Bei Wu; David A Harris
Journal:  Brain Pathol       Date:  2019-01-17       Impact factor: 6.508

4.  The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.

Authors:  Tiziana Sonati; Regina R Reimann; Jeppe Falsig; Pravas Kumar Baral; Tracy O'Connor; Simone Hornemann; Sine Yaganoglu; Bei Li; Uli S Herrmann; Barbara Wieland; Mridula Swayampakula; Muhammad Hafizur Rahman; Dipankar Das; Nat Kav; Roland Riek; Pawel P Liberski; Michael N G James; Adriano Aguzzi
Journal:  Nature       Date:  2013-07-31       Impact factor: 49.962

5.  Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates.

Authors:  Ilan Margalith; Carlo Suter; Boris Ballmer; Petra Schwarz; Cinzia Tiberi; Tiziana Sonati; Jeppe Falsig; Sofie Nyström; Per Hammarström; Andreas Aslund; K Peter R Nilsson; Alice Yam; Eric Whitters; Simone Hornemann; Adriano Aguzzi
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

6.  The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.

Authors:  Patrick Walsh; Gillian Vanderlee; Jason Yau; Jody Campeau; Valerie L Sim; Christopher M Yip; Simon Sharpe
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

7.  Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.

Authors:  Dilshan S Harischandra; Naveen Kondru; Dustin P Martin; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

Review 8.  Identification of anti-prion drugs and targets using toxicity-based assays.

Authors:  Robert Cc Mercer; David A Harris
Journal:  Curr Opin Pharmacol       Date:  2019-01-23       Impact factor: 5.547

9.  Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.

Authors:  Aline Bamia; Maha Sinane; Rima Naït-Saïdi; Jamila Dhiab; Frédéric Bihel; Cécile Voisset; Marc Keruzoré; Phu Hai Nguyen; Agathe Bertho; Flavie Soubigou; Sophie Halliez; Marc Blondel; Capucine Trollet; Martine Simonelig; Gaëlle Friocourt; Vincent Béringue
Journal:  Neurotherapeutics       Date:  2021-02-02       Impact factor: 7.620

10.  RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1.

Authors:  Jeehye Park; Ismael Al-Ramahi; Qiumin Tan; Nissa Mollema; Javier R Diaz-Garcia; Tatiana Gallego-Flores; Hsiang-Chih Lu; Sarita Lagalwar; Lisa Duvick; Hyojin Kang; Yoontae Lee; Paymaan Jafar-Nejad; Layal S Sayegh; Ronald Richman; Xiuyun Liu; Yan Gao; Chad A Shaw; J Simon C Arthur; Harry T Orr; Thomas F Westbrook; Juan Botas; Huda Y Zoghbi
Journal:  Nature       Date:  2013-05-29       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.